Selective inhibition of Src protein tyrosine kinase by analogues of 5-S-glutathionyl-beta-alanyl-L-dopa

Chem Pharm Bull (Tokyo). 1998 Dec;46(12):1950-1. doi: 10.1248/cpb.46.1950.

Abstract

Twelve analogues of the antibacterial phenolic peptide 5-S-glutathionyl-beta-alanyl-L-dopa (5-S-GA-L-D: 1) were synthesized via orthoquinones using tyrosinase. Several synthesized compounds inhibited the v-Src autophosphorylation tyrosine kinase reaction with an IC50 value comparable to that of herbimycin. The inhibition of c-Src substrate phosphorylation was much less active than v-Src autophosphorylation inhibition. The analogues showed no effects on substrate phosphorylation by epidermal growth factor receptor (EGFR), and this selectivity is the most characteristic feature of the analogues (1-12).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Enzyme Inhibitors / chemistry
  • Enzyme Inhibitors / pharmacology*
  • Glutathione / analogs & derivatives*
  • Glutathione / chemistry
  • Glutathione / pharmacology
  • Levodopa / analogs & derivatives*
  • Levodopa / chemistry
  • Levodopa / pharmacology
  • Molecular Structure
  • Phosphorylation
  • src-Family Kinases / antagonists & inhibitors*
  • src-Family Kinases / metabolism

Substances

  • 5-S-glutathionyl-beta-alanyl-L-DOPA
  • Enzyme Inhibitors
  • Levodopa
  • src-Family Kinases
  • Glutathione